PI3K inhibitor
This page covers all PI3K inhibitor drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting PI3K, PI3K (phosphatidylinositol 3-kinase), PI3K (phosphoinositide 3-kinase).
Targets
PI3K · PI3K (phosphatidylinositol 3-kinase) · PI3K (phosphoinositide 3-kinase) · PI3K (phosphatidylinositol 3-kinase), pan-class I · PI3K delta and PI3K gamma · PI3K delta
Phase 3 pipeline (24)
- AD-2021 · Addpharma Inc. · Oncology
AD-2021 is a small molecule that targets the PI3K/AKT pathway to inhibit cancer cell growth. - 1PC111 · Orient Pharma Co., Ltd. · Oncology
This drug is a small molecule that targets the PI3K/AKT pathway. - Prodiax-23 · SK Chemicals Co., Ltd. · Oncology
Prodiax-23 is a small molecule that targets the PI3K/AKT pathway. - SHR0302 · Jiangsu HengRui Medicine Co., Ltd. · Oncology
SHR0302 is a small molecule that targets the PI3K/AKT/mTOR pathway. - PTX-022 · Palvella Therapeutics, Inc. · Oncology
PTX-022 is a selective inhibitor of phosphatidylinositol 3-kinase (PI3K) designed to modulate immune cell function and tumor microenvironment. - ONO-4059 · Ono Pharmaceutical Co. Ltd · Oncology
ONO-4059 is a small-molecule inhibitor of phosphoinositide 3-kinase (PI3K) that blocks PI3K signaling to suppress tumor cell proliferation and survival. - D-2570 · InventisBio Co., Ltd · Oncology
D-2570 is a small molecule that targets the PI3K/AKT pathway. - BAY86-4980 · Bayer · Oncology
BAY86-4980 is a selective inhibitor of phosphoinositide 3-kinase (PI3K) that blocks PI3K signaling to suppress tumor cell proliferation and survival. - AD-2281 · Addpharma Inc. · Oncology
AD-2281 is a small molecule that targets the PI3K/AKT pathway. - PLC · Sigma-Tau Research, Inc. · Oncology
PLC is a drug that targets the PI3K/AKT pathway. - Haporine-S · DH Bio Co., Ltd. · Oncology
Haporine-S is a small molecule that targets the PI3K/AKT/mTOR pathway. - TCA108 · EMS · Oncology
TCA108 is a small molecule that targets the PI3K/AKT/mTOR pathway. - 1PC002 · Orient Pharma Co., Ltd. · Oncology
This drug is a small molecule that targets the PI3K/AKT/mTOR pathway. - YK-209A tablet · Suzhou Puhe Pharmaceutical Technology Co., LTD · Oncology
YK-209A tablet is a small molecule that targets the PI3K/AKT signaling pathway. - NALIRI · Cancer Institute and Hospital, Chinese Academy of Medical Sciences · Oncology
NALIRI is a small molecule that targets the PI3K/AKT/mTOR pathway. - AD-2091 · Addpharma Inc. · Oncology
AD-2091 is a small molecule that targets the PI3K/AKT pathway to inhibit cancer cell growth. - D-1553 · InventisBio Co., Ltd · Oncology
D-1553 is a small molecule that targets the PI3K/AKT/mTOR pathway. - SBR759A · Novartis · Oncology
SBR759A is a small molecule that targets the PI3K pathway. - GDC-229 · Balmoral Medical company · Oncology
GDC-229 is a small molecule targeting the PI3K pathway. - AG20011 · Ahn-Gook Pharmaceuticals Co.,Ltd · Oncology
AG20011 is a small molecule targeting the PI3K/AKT/mTOR pathway. - Copanlisib (BAY 80-6946) · Bayer · Oncology
Copanlisib is a pan-class I phosphatidylinositol 3-kinase (PI3K) inhibitor that blocks PI3K signaling to suppress tumor cell proliferation and survival. - AG20012 · Ahn-Gook Pharmaceuticals Co.,Ltd · Oncology
AG20012 is a small molecule that targets the PI3K/AKT/mTOR pathway. - AD-2022 · Addpharma Inc. · Oncology
AD-2022 is a small molecule that targets the PI3K/AKT pathway. - BAY86-5300 · Bayer · Oncology
BAY86-5300 is a selective inhibitor of phosphoinositide 3-kinase (PI3K) that blocks PI3K signaling to suppress tumor cell proliferation and survival.
Phase 2 pipeline (22)
- MBM-02 · Matrix Biomed, Inc. · Oncology
MBM-02 is a small molecule that targets the PI3K/AKT pathway. - CAL-101 · German CLL Study Group · Oncology
CAL-101 is a selective, irreversible inhibitor of phosphatidylinositol 3-kinase (PI3K). - B007 · Shanghai Jiaolian Drug Research and Development Co., Ltd · Oncology
B007 is a small molecule that targets the PI3K/AKT signaling pathway. - BB-101 · Blue Blood Biotech Corp. · Oncology
BB-101 is a small molecule that targets the PI3K pathway. - GEn-1124 · GEn1E Lifesciences · Oncology
GEn-1124 is a small molecule that targets the PI3K/AKT pathway. - AON-D21 · Aptarion Biotech AG · Oncology
AON-D21 is a small molecule that targets the PI3K/AKT/mTOR pathway. - AMOR-1 · Amorphical Ltd. · Oncology
AMOR-1 is a small molecule that targets the PI3K/AKT signaling pathway. - AB1010 · AB Science · Oncology
AB1010 is a small molecule that targets the PI3K pathway. - BPM31510 Nanosuspension Injection · BPGbio · Oncology
BPM31510 is a nanosuspension formulation of buparlisib that inhibits phosphatidylinositol 3-kinase (PI3K) to block tumor cell proliferation and survival signaling. - AZD3241 · AstraZeneca · Oncology
AZD3241 is a small molecule inhibitor of the PI3K delta and PI3K gamma enzymes. - AlphaMedix · Orano Med LLC · Oncology
AlphaMedix is a small molecule that targets the PI3K/AKT pathway to inhibit cancer cell proliferation. - AEVI-001 · Aevi Genomic Medicine, LLC, a Cerecor company · Oncology
AEVI-001 is a small molecule drug that targets the PI3K/AKT pathway. - AZD8931 · AstraZeneca · Oncology
AZD8931 is a PI3K inhibitor. - BEY2153 · BeyondBio Inc. · Oncology
BEY2153 is a small molecule that targets the PI3K pathway. - BA3021 · Canadian Cancer Trials Group · Oncology
BA3021 is a small molecule targeting the PI3K pathway. - AZD6234 · AstraZeneca · Oncology
AZD6234 is a small molecule inhibitor of the PI3K delta and PI3K gamma enzymes. - DA-001 · Applied Biology, Inc. · Oncology
DA-001 is a small molecule that targets the PI3K/AKT pathway. - AV-001 · Vasomune Therapeutics, Inc. · Oncology
AV-001 is a small molecule that targets the PI3K pathway to modulate immune responses. - CT-2106 · CTI BioPharma · Oncology
CT-2106 is a small molecule inhibitor of the PI3K delta and PI3K gamma enzymes. - BCD-236 · Biocad · Oncology
BCD-236 is a small molecule that targets the PI3K/AKT pathway. - AGA2115 · Angitia Incorporated Limited · Oncology
AGA2115 is a small molecule drug that targets the PI3K/AKT/mTOR pathway. - BB-031 · Basking Biosciences, Inc. · Oncology
BB-031 is a small molecule that targets the PI3K pathway.